Dr. Paul C. Lee

Dr. Paul C. Lee is the System Director of Thoracic Surgery at Northwell Health. Board certified in both general surgery and cardiothoracic surgery, he has over 17 years of experience as a thoracic surgeon and specializes in treating benign and malignant disorders of the lung and esophagus. He uses the most advanced minimally invasive robotic techniques, which improve surgical precision and quicken patient recovery.

Dr. Lee leads the busiest thoracic surgery program in the New York City area, and is based at Long Island Jewish Medical Center. Under his direction, the program has been recognized by the Surgical Review Corporation as America's first Robotic Surgery Network of Excellence, a true testament to Dr. Lee's ongoing dedication to delivering innovative care.

Dr. Lee's patients choose him not only for his results, but also for his accessibility and compassion. He understands the uncertainty that often comes with a health event or new diagnosis, as the majority of his patients are dealing with cancer. He takes the time to get to know every patient, ensuring the most individualized, compassionate care. He also offers same and next day appointments whenever possible.

Collaboration is key to Dr. Lee's approach to treatment. He participates in weekly thoracic tumor boards, where specialists across many disciplines come together to discuss cases and decide on treatment plans uniquely tailored for each patient.

Dr. Lee's expertise was honed at some of the finest educational institutions in the world, including Harvard University, Johns Hopkins University School of Medicine and Columbia University. Now at the top of his field, he's passionate about passing on his knowledge to other medical professionals. He's a Professor of Cardiovascular and Thoracic surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He also mentors fellow surgeons at Northwell and beyond, training them in the latest robotic thoracic surgery techniques. He has published more than 100 peer-reviewed articles and has given presentations at many national and international scientific meetings in the fields of cardiopulmonary physiology, molecular cell biology and thoracic oncology.

Research is also important to Dr. Lee. He has been the principal investigator of several innovative biological research trials for the treatment of lung and esophageal cancer. He's especially interested in the use of health outcome and quality metrics research in improving the delivery of thoracic surgical services to the community.

Dr. Lee is a member of various prestigious medical societies including the American College of Surgeons, the American College of Chest Physicians, Society of Thoracic Surgeons, American Society of Clinical Oncology and American Association for Thoracic Surgeons. He also served as the President of the Chinese American Medical Society from 2015 to 2017.

Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Thymectomy, and Endoscopy.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.